J Vasc Interv Radiol. 2007 May;18(5):659-62.

Treatment of a large type II endoleak via extraperitoneal dissection and embolization of a collateral vessel using ethylene vinyl alcohol copolymer (Onyx).

Ling AJ, Pathak R, Garbowski M, Nadkarni S.

Source

Department of Vascular Surgery, Sir Charles Gairdner Hospital, Western Australia 6008, Australia. adrianling@hotmail.com

Abstract

Type II endoleak is defined as persistent blood flow and pressure within an aneurysmal sac after endovascular deployment of a stent graft from patent aortic branches. This paper describes the simultaneous deployment of an endoluminal graft, with limited extraperitoneal dissection of a collateral vessel and use of an ethylene vinyl alcohol copolymer, Onyx, to obliterate a large type II endoleak.

PMID:: 17494849; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Supplemental Content

Related citations

Treatment of type II endoleaks with a novel polyurethane thrombogenic foam: induction of endoleak thrombosis and elimination of intra-aneurysmal pressure in the canine model. [J Vasc Surg. 2005]
Treatment of type II endoleaks with a novel polyurethane thrombogenic foam: induction of endoleak thrombosis and elimination of intra-aneurysmal pressure in the canine model.
Rhee JY, Trocciola SM, Dayal R, Lin S, Chaer R, Kumar N, Mousa A, Bernheim J, Christos P, Prince M, et al. J Vasc Surg. 2005 Aug; 42(2):321-8.
Regarding "endoluminal treatment of type IA endoleak with Onyx". [J Vasc Surg. 2011]
Regarding "endoluminal treatment of type IA endoleak with Onyx".
Loffroy R, Steinmetz E. J Vasc Surg. 2011 Apr; 53(4):1163; author reply 1163-4.
Characterization of retrograde collateral (type II) endoleak using a new canine model. [J Vasc Surg. 2004]
Characterization of retrograde collateral (type II) endoleak using a new canine model.
Dayal R, Mousa A, Bernheim J, Hollenbeck S, Henderson P, Prince M, Gordon R, Badimon J, Fuster V, Marin ML, et al. J Vasc Surg. 2004 Nov; 40(5):985-94.
Review [Classification and treatment of endoleaks after endovascular treatment of abdominal aortic aneurysms]. [Rofo. 2005]
Review [Classification and treatment of endoleaks after endovascular treatment of abdominal aortic aneurysms].
Pitton MB, Schmiedt W, Neufang A, Düber C, Thelen M. Rofo. 2005 Jan; 177(1):24-34.
Review Management of type II endoleaks: preoperative versus postoperative versus expectant management. [Semin Vasc Surg. 2009]
Review Management of type II endoleaks: preoperative versus postoperative versus expectant management.
Jonker FH, Aruny J, Muhs BE. Semin Vasc Surg. 2009 Sep; 22(3):165-71.

See reviews... See all...

Cited by 1 PubMed Central article

Management of Endoleaks following Endovascular Aneurysm Repair. [Semin Intervent Radiol. 2009]
Management of Endoleaks following Endovascular Aneurysm Repair.
White SB, Stavropoulos SW. Semin Intervent Radiol. 2009 Mar; 26(1):33-8.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Treatment of a large type II endoleak via extraperitoneal dissection and emboliz...
Treatment of a large type II endoleak via extraperitoneal dissection and embolization of a collateral vessel using ethylene vinyl alcohol copolymer (Onyx).
J Vasc Interv Radiol. 2007 May ;18(5):659-62.

PubMed
Protein crystallography for non-crystallographers, or how to get the best (but n...
Protein crystallography for non-crystallographers, or how to get the best (but not more) from published macromolecular structures.
FEBS J. 2008 Jan ;275(1):1-21. Epub 2007 Nov 23 .

PubMed
Etoposide pathway.
Etoposide pathway.
Pharmacogenet Genomics. 2009 Jul ;19(7):552-3.

PubMed
Ganser's syndrome.
Ganser's syndrome.
Lancet. 2004 Jul 31-Aug 6 ;364(9432):471-3.

PubMed
The power-law distribution of gene family size is driven by the pseudogenisation...
The power-law distribution of gene family size is driven by the pseudogenisation rate's heterogeneity between gene families.
Gene. 2008 May 15 ;414(1-2):85-94. Epub 2008 Mar 10 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Treatment of a large type II endoleak via extraperitoneal dissection and embolization of a collateral vessel using ethylene vinyl alcohol copolymer (Onyx).

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Related citations

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information